Learn why leading cancer programs are developing a toxicity team for patients on cancer immunotherapies, and how to build a toxicity team for your I-O program.
Jarushka Naidoo, M.B.B.Ch.
Assistant Professor of Oncology, Department of Oncology
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Laura Cappelli, MD, MHS
Assistant Professor of Medicine, Division of Rheumatology
Johns Hopkins School of Medicine
Jennifer Mammen, MD, PhD
Assistant Professor of Medicine, Division of Endocrinology, Diabetes and Metabolism
Johns Hopkins University School of Medicine
This webinar is made possible by a charitable donation from Bristol-Myers Squibb and supported by an educational grant from Merck & Co., Inc.
View On-Demand Replay